Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolism Disorder, Lipid”

4,973 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,973 results

Testing effectiveness (Phase 2)Temporarily pausedNCT03097107
What this trial is testing

Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL

Who this might be right for
Dyslipidemias
Zydus Therapeutics Inc. 124
Not applicableNot Yet RecruitingNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Large-scale testing (Phase 3)Study completedNCT04929249
What this trial is testing

Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE)

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 450
Early research (Phase 1)Study completedNCT01671085
What this trial is testing

LY3015014 in Healthy Participants With High Cholesterol

Who this might be right for
Healthy VolunteersHypercholesterolemia
Eli Lilly and Company 13
Early research (Phase 1)Study completedNCT02156544
What this trial is testing

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Who this might be right for
Dyslipidemia
Chong Kun Dang Pharmaceutical 41
Not applicableStudy completedNCT00005134
What this trial is testing

Strong Heart Study

Who this might be right for
Cardiovascular DiseasesHeart DiseasesAtherosclerosis+7 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT03836443
What this trial is testing

Postprandial Lipotoxicity and Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Assistance Publique - Hôpitaux de Paris 30
Not applicableUnknownNCT01898325
What this trial is testing

Assessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using Fibroscan

Who this might be right for
Fibrosis
Rambam Health Care Campus 40
Not applicableActive Not RecruitingNCT05526664
What this trial is testing

Omics Gaucher Study: Multiomic Approach

Who this might be right for
Gaucher Disease
CENTOGENE GmbH Rostock 25
Not applicableStudy completedNCT05124847
What this trial is testing

TREating Pediatric Obesity

Who this might be right for
Infant ObesityHepatic SteatosisMetabolic Syndrome+2 more
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 30
Not applicableStudy completedNCT04448067
What this trial is testing

Dietary Incorporation of Lentils to Improve Metabolic Health

Who this might be right for
Waist, Hypertriglyceridemic
Montana State University 35
Early research (Phase 1)Study completedNCT02536911
What this trial is testing

The Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

Who this might be right for
Gaucher Disease
Genzyme, a Sanofi Company 24
Early research (Phase 1)Study completedNCT03609606
What this trial is testing

Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects

Who this might be right for
DyslipidemiasHypertension
Chong Kun Dang Pharmaceutical 69
Not applicableStudy completedNCT00531037
What this trial is testing

Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers

Who this might be right for
Patients Implanted With a Pacemaker
LivaNova 1,440
Large-scale testing (Phase 3)Study completedNCT02622672
What this trial is testing

Water-soluble Ubiquinol Supplementation on Blood Glucose, Lipids, Oxidative Stress, and Inflammation in Diabetes

Who this might be right for
Diabetes
Yeh 50
Not applicableStudy completedNCT00728364
What this trial is testing

Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy

Who this might be right for
Focus of Study: Prevalence of Fabry Disease in CKD Population
Klinikum Wels-Grieskirchen 4,353
Post-approval studies (Phase 4)Study completedNCT00397826
What this trial is testing

Evaluation of the Effects of Simvastatin 40mg

Who this might be right for
Hypercholesterolemia
Cardinal Tien Hospital 20
Post-approval studies (Phase 4)Study completedNCT01624207
What this trial is testing

The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg

Who this might be right for
Hypercholesterolemia
Seoul National University Hospital 376
Not applicableStudy completedNCT06350604
What this trial is testing

Project WHADE: A Partner-Based Physical Activity Program for Women

Who this might be right for
HypertensionType 2 DiabetesMetabolic Syndrome+4 more
Rowan University 62
Not applicableStudy completedNCT05542147
What this trial is testing

Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate

Who this might be right for
Type 2 DiabetesCardiovascular DiseasesPharmacogenomic Drug Interaction
Mario Luca Morieri 200
Load More Results